RACHAEL BENNETT: Open Payments
NPI 1134764590 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,685 in 186 payments from 30 companies in 2025. Trend: 2023 $2,858 · 2024 $3,528 · 2025 $3,685
Food & beverage: $3,685
| Company | Payments | Amount |
|---|---|---|
| Lundbeck LLC | 18 | $357 |
| UCB, Inc. | 15 | $307 |
| PFIZER INC. | 16 | $282 |
| Novartis Pharmaceuticals Corporation | 12 | $282 |
| Eisai Inc. | 16 | $274 |
| Genentech USA, Inc. | 8 | $180 |
| Celgene Corporation | 10 | $164 |
| Teva Pharmaceuticals USA, Inc. | 8 | $157 |
| Alexion Pharmaceuticals, Inc. | 5 | $157 |
| Amneal Pharmaceuticals LLC | 7 | $147 |
Products named: KESIMPTA, Leqembi, REXULTI, NURTEC ODT, ZEPOSIA, ULTOMIRIS, Ocrevus Zunovo, CREXONT.
Industry payments across AZ — which companies pay providers there.
